1. ACIP – Advisory Committee on Immunization Practices. 2008. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants. MMWR Morbid. Mortal. Wkly. Rep. 57(RR-4), pp. 1–51.
2. ACIP – Advisory Committee on Immunization Practices. 2011. Updated recommendations for use of tetanus toxoid, reduced diphteria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months. MMWR Morbid. Mortal. Wkly. Rep 60(41), pp. 1424–1426.
3. Pertussis: increasing disease as a consequence of reducing transmission;Aguas;The Lancet Infectious Diseases,2006
4. Cell-mediated immune responses in four-year-old children after primary immunization with a cellular pertussis vaccines;Ausiello;Infection and Immunity,1999
5. Predicted long-term persistence of pertussis antibodies in tetanus, diphtheria and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data;Baillleux;Vaccine,2008